Cantabio Pharmaceuticals, Inc. Share Price
Equities
CTBO
US13808X2036
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.01 USD | -95.96% | -.--% | -.--% |
Sales 2017 | - | Sales 2018 | - | Capitalization | 2.36M 197M |
---|---|---|---|---|---|
Net income 2017 | -1M -83.49M | Net income 2018 | -2M -167M | EV / Sales 2017 | - |
Net Debt 2017 | 337K 28.15M | Net Debt 2018 | 1.1M 91.45M | EV / Sales 2018 | - |
P/E ratio 2017 * |
-
| P/E ratio 2018 |
-
| Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 29.99% |
1 day | -95.96% |
Managers | Title | Age | Since |
---|---|---|---|
Gergely Tóth
FOU | Founder | 51 | 06/12/06 |
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22/15/22 |
Max Zhu
BRD | Director/Board Member | 42 | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Sawyer
DFI | Director of Finance/CFO | 54 | 22/15/22 |
Gergely Tóth
FOU | Founder | 51 | 06/12/06 |
Max Zhu
BRD | Director/Board Member | 42 | 01/15/01 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 24.35K | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CTBO Stock